F Miedema - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F Miedema

Showing results (101-110 of 180) with videos related to

Pageof 18

Sort By:

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997

Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxisJ Veenstra, P J Veugelers, I P Keet, et al.

The Journal of Infectious Diseases|September 1, 1993

Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.

AIDS (London, England)|April 15, 1999

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.

Journal of Leukocyte Biology|August 1, 1994

Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAbF J van Kemenade, F T Rotteveel, L A van den Broek, et al.

Immunology Letters|April 15, 1999

Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionO Pontesilli, S Kerkhof-Garde, N G Pakker, et al.

AIDS (London, England)|June 1, 1993

Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequenciesC A van Baalen, M R Klein, A M Geretti, et al.

Clinical and Diagnostic Laboratory Immunology|July 7, 2000

Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assayT Messele, M T Roos, D Hamann, et al.

The Journal of Infectious Diseases|July 29, 2000

Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humansM T Roos, R A van Lier, D Hamann, et al.

AIDS Research and Human Retroviruses|July 1, 1993

Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropismH Schuitemaker, M Groenink, L Meyaard, et al.

AIDS (London, England)|December 31, 1997

AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversionF de Wolf, I Spijkerman, P T Schellekens, et al.

Pageof 18

Search research articles

Showing results (101-110 of 180) with videos related to

Sort By:

Pageof 18

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997

Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxisJ Veenstra, P J Veugelers, I P Keet, et al.

The Journal of Infectious Diseases|September 1, 1993

Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.

AIDS (London, England)|April 15, 1999

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.

Journal of Leukocyte Biology|August 1, 1994

Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAbF J van Kemenade, F T Rotteveel, L A van den Broek, et al.

Immunology Letters|April 15, 1999

Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionO Pontesilli, S Kerkhof-Garde, N G Pakker, et al.

AIDS (London, England)|June 1, 1993

Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequenciesC A van Baalen, M R Klein, A M Geretti, et al.

Clinical and Diagnostic Laboratory Immunology|July 7, 2000

Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assayT Messele, M T Roos, D Hamann, et al.

The Journal of Infectious Diseases|July 29, 2000

Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humansM T Roos, R A van Lier, D Hamann, et al.

AIDS Research and Human Retroviruses|July 1, 1993

Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropismH Schuitemaker, M Groenink, L Meyaard, et al.

AIDS (London, England)|December 31, 1997

AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversionF de Wolf, I Spijkerman, P T Schellekens, et al.

Pageof 18